Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Chapurlat

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Joint Bone Spine|May 11, 2013
Contribution and limitations of the FRAX® toolRoland Chapurlat
La Revue Du Praticien|March 14, 2012
[Osteoporosis without fracture: when do we treat?]Roland Chapurlat
Best Practice & Research. Clinical Endocrinology & Metabolism|February 19, 2022
Regulation of bone mass: A splendid OrchestraRoland Chapurlat
Joint Bone Spine|February 28, 2016
Cathepsin K inhibitors and antisclerostin antibodies. The next treatments for osteoporosis?Roland Chapurlat
Journal De La Societe De Biologie|December 20, 2008
[Epidemiology of osteoporosis]Roland Chapurlat
Joint Bone Spine|January 11, 2018
Effects and management of denosumab discontinuationRoland Chapurlat
Joint Bone Spine|February 15, 2016
Is it time for treat to target strategy in osteoporosis?Roland Chapurlat
Joint Bone Spine|April 27, 2005
Current pharmacological treatment for fibrous dysplasia and perspectives for the futureRoland Chapurlat
Bonekey Reports|June 28, 2016
In vivo evaluation of bone microstructure in humans: Clinically useful?Roland Chapurlat
La Revue Du Praticien|March 14, 2012
[Indications of bone densitometry]Roland Chapurlat
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Joint Bone Spine|May 11, 2013
Contribution and limitations of the FRAX® toolRoland Chapurlat
La Revue Du Praticien|March 14, 2012
[Osteoporosis without fracture: when do we treat?]Roland Chapurlat
Best Practice & Research. Clinical Endocrinology & Metabolism|February 19, 2022
Regulation of bone mass: A splendid OrchestraRoland Chapurlat
Joint Bone Spine|February 28, 2016
Cathepsin K inhibitors and antisclerostin antibodies. The next treatments for osteoporosis?Roland Chapurlat
Journal De La Societe De Biologie|December 20, 2008
[Epidemiology of osteoporosis]Roland Chapurlat
Joint Bone Spine|January 11, 2018
Effects and management of denosumab discontinuationRoland Chapurlat
Joint Bone Spine|February 15, 2016
Is it time for treat to target strategy in osteoporosis?Roland Chapurlat
Joint Bone Spine|April 27, 2005
Current pharmacological treatment for fibrous dysplasia and perspectives for the futureRoland Chapurlat
Bonekey Reports|June 28, 2016
In vivo evaluation of bone microstructure in humans: Clinically useful?Roland Chapurlat
La Revue Du Praticien|March 14, 2012
[Indications of bone densitometry]Roland Chapurlat
Pageof 27